Analyzing the forecast for the import of Rutoside (Rutin) to China from 2024 to 2028, there is a consistent downward trend in volume, decreasing from 80.32 to 77.93 thousand kilograms. This suggests a gradual reduction in imports, with a year-on-year decline. Assuming the 2023 value was higher, it underlines a continuous downward movement. The compound annual growth rate (CAGR) indicates a modest contraction over these years.
Future trends to watch for include:
- Potential impacts of domestic production on import demand.
- Shifts in health and pharmaceutical market dynamics affecting Rutoside usage.
- Global trade conditions influencing China's import capabilities.
